Clinical role of brexpiprazole in depression and schizophrenia
Nishant B Parikh, Diana M Robinson, Anita H Clayton Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA Abstract: Brexpiprazole, a serotonin–dopamine activity modulator, is the second D2 partial agonist to come to market and has been a...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017-03-01
|
| Edice: | Therapeutics and Clinical Risk Management |
| Témata: | |
| On-line přístup: | https://www.dovepress.com/clinical-role-of-brexpiprazole-in-depression-and-schizophrenia-peer-reviewed-article-TCRM |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|